Viewing Study NCT00589667

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:37 AM
Ignite Modification Date: 2026-01-03 @ 10:07 AM
Study NCT ID: NCT00589667
Status: COMPLETED
Last Update Posted: 2014-04-02
First Post: 2007-12-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase II Study of Pemetrexed Plus Gemcitabine for Metastatic/Recurrent Head and Neck Cancer (HNSCC)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Head and Neck Cancer View
None GEMCITABINE View
None PEMETREXED View
None ALTIMA View
None epidermoid/squamous cell View
None carcinoma View
None pharynx View
None larynx View
None paranasal sinus View
None head/neck squamous cell carcinoma View